Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

EyePoint, Inc. (EYPT)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

EyePoint issued a press release on August 5, 2026, announcing financial results for the quarter ended June 30, 2026, including consolidated balance sheets and statements of operations. The disclosure includes quarterly revenue ($0.5M vs. $5.3M prior year), operating expenses ($97.9M vs. $67.6M), and net loss ($94.5M or $1.09 per share). This is a standard quarterly earnings release filed under Item 2.02, material to investors assessing the company's financial condition and cash runway into Q4 2027.

View raw filing on EDGAR →

SPIRE INC (SRJN)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Spire Inc. disclosed fiscal 2026 third quarter financial results ended June 30, 2026, reporting a net loss from continuing operations of $42.6 million ($(0.72) per diluted share) and adjusted loss from continuing operations of $15.7 million ($(0.26) per share), along with reaffirmed fiscal 2026 and 2027 earnings guidance.

View raw filing on EDGAR →

NewAmsterdam Pharma Co N.V. (NAMSW)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

NewAmsterdam Pharma issued a press release on August 5, 2026, announcing financial results for the quarter ended June 30, 2026, including cash position ($678.3 million), revenue ($3.7 million), R&D expenses ($41.7 million), SG&A expenses ($26.9 million), and net loss ($64.1 million). The disclosure is a standard quarterly earnings announcement with detailed financial metrics and operational updates, furnished as Exhibit 99.1 under Item 2.02.

View raw filing on EDGAR →

Kymera Therapeutics, Inc. (KYMR)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Kymera Therapeutics disclosed its financial results for the quarter ended June 30, 2026, via a press release furnished as Exhibit 99.1. The disclosure includes quarterly financial metrics (collaboration revenues of $65.0 million, R&D expenses of $119.5 million, net loss of $61.2 million) and cash position ($1.5 billion), along with business updates on clinical pipeline progress. This is a standard quarterly earnings release under Item 2.02, material to investors assessing the company's financial condition and operational progress.

View raw filing on EDGAR →

THOMSON REUTERS CORP /CAN/ (TMSOF)

6-K Earnings release confidence 98% filed 2026-08-05 EX-99.1

This is a press release announcing Thomson Reuters' second-quarter 2026 financial results, including consolidated revenue, operating profit, diluted EPS, and adjusted EBITDA figures for both the three-month and six-month periods ended June 30, 2026, along with updated full-year 2026 guidance. The document explicitly states "Thomson Reuters Reports Second-Quarter 2026 Results" and presents detailed financial metrics and segment performance data typical of a quarterly earnings announcement.

View raw filing on EDGAR →

EXTREME NETWORKS INC (EXTR)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a standard earnings release disclosing Extreme Networks' fourth quarter and fiscal year 2026 financial results. The filing explicitly states "On August 5, 2026, Extreme Networks, Inc. (the "Company") issued a press release announcing certain financial results for its fourth quarter and fiscal year ended June 30, 2026," with the press release furnished as Exhibit 99.1. The disclosure includes detailed GAAP and non-GAAP results, revenue growth metrics (13% year-over-year), SaaS ARR growth (18%), and forward guidance for Q1 and full-year FY2027, all typical of a quarterly earnings announcement.

View raw filing on EDGAR →

Advantage Solutions Inc. (ADV)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a clear earnings release disclosing Q2 2026 financial results for Advantage Solutions Inc. The Item 2.02 filing announces revenues of $889.5 million (up 1.8% YoY), net loss of $62.7 million (vs. $30.4 million loss in prior year), and Adjusted EBITDA of $75.8 million (down 12.2% YoY). The press release is attached as Exhibit 99.1 and includes segment performance, cash flow highlights, and full-year guidance reiterations. This is a material disclosure affecting investor assessment of the company's financial condition and operating performance.

View raw filing on EDGAR →

Dine Brands Global, Inc. (DIN)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Dine Brands issued a press release on August 5, 2026, announcing its second quarter 2026 financial results, including total revenues of $240.9 million, net income of $4.2 million ($0.35 EPS), and adjusted EBITDA of $54.2 million. The disclosure is a standard quarterly earnings announcement with detailed financial metrics, comparable sales data, and forward guidance, clearly fitting the earnings_release category.

View raw filing on EDGAR →

Rapport Therapeutics, Inc. (RAPP)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

This is a quarterly earnings release for Q2 2026 filed under Item 2.02. The disclosure includes financial results (net loss of $56.6M, R&D expenses of $51.4M, cash position of $436.1M), condensed consolidated financial statements, and business highlights regarding clinical trial progress for RAP-219 and pipeline advancement. The press release is furnished as Exhibit 99.1, which is the standard format for earnings disclosures under Item 2.02.

View raw filing on EDGAR →

ContextLogic Holdings Inc. (LOGC)

8-K Earnings release confidence 75% filed 2026-08-05 Item 2.02

ContextLogic disclosed preliminary estimated financial results for Q2 2026, showing revenue of $33.6 million (essentially flat vs. $33.8 million in Q2 2025) and gross profit of $12.5 million (down from $13.7 million in Q2 2025), reflecting volume declines and pricing changes.

View raw filing on EDGAR →

Trinity Capital Inc. (TRINZ)

8-K Earnings release confidence 97% filed 2026-08-05 Item 2.02

Trinity Capital issued a press release and earnings presentation on August 5, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing net investment income of $46.0 million ($0.51 per share), total investment income of $87.2 million (up 25.5% year-over-year), and a 15.2% return on average equity.

View raw filing on EDGAR →

ImageneBio, Inc. (IMA)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

ImageneBio disclosed its financial results for the quarter ended June 30, 2026 via press release attached as Exhibit 99.1, including condensed consolidated balance sheets and statements of operations. This is a standard quarterly earnings release filed under Item 2.02, with specific financial metrics (R&D expenses of $6.7M, G&A expenses of $5.1M, net loss of $10.2M) and cash position ($136.2M) that would materially inform investor assessment of the company's financial condition and runway.

View raw filing on EDGAR →

SmartRent, Inc. (SMRT)

8-K Earnings release confidence 97% filed 2026-08-05 Item 2.02

SmartRent issued a press release on August 5, 2026, announcing its financial results for the second quarter ended June 30, 2026, reporting total revenue of $39.8 million (up 4% YoY), core revenue of $38.4 million (up 14% YoY), Adjusted EBITDA of $0.7 million, and a net loss of $5.6 million, along with operational highlights and forward-looking guidance.

View raw filing on EDGAR →

Global Indemnity Group, LLC (GBLI)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Global Indemnity Group issued a press release on August 5, 2026 announcing financial results for the three and six months ended June 30, 2026. The disclosure includes detailed quarterly and year-to-date net income ($11.1M and $15.3M respectively), earnings per share ($0.76 and $1.05), underwriting income, premium growth metrics, and consolidated financial statements. This is a standard earnings release disclosure under Item 2.02 that would materially affect a reasonable investor's assessment of the registrant's financial performance.

View raw filing on EDGAR →

INTERNATIONAL BATTERY METALS LTD. (IBATF)

8-K Earnings release confidence 94% filed 2026-08-05 Item 2.02

International Battery Metals announced a conference call to discuss financial and operational results for the first quarter of fiscal year 2027 ended June 30, 2026, with a press release to be issued before market open on August 13, 2026.

View raw filing on EDGAR →

AMERICAN FINANCIAL GROUP INC (AFGE)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a clear earnings release disclosing American Financial Group's second quarter 2026 financial results. The filing explicitly references "the announcement of the Company's results of operations for the second quarter of 2026" with a press release issued on August 4, 2026, furnished as Exhibit 99.1. The press release reports net earnings of $248 million ($2.99 per share), core net operating earnings of $234 million ($2.82 per share), and key operational metrics including a record second quarter pretax P&C operating income of $350 million and 20.3% annualized ROE.

View raw filing on EDGAR →

NNN REIT, INC. (NNN)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

NNN REIT issued a press release on August 5, 2026 announcing its financial and operating results for the quarter and six months ended June 30, 2026. The disclosure includes detailed financial metrics (net earnings, FFO, Core FFO, AFFO per diluted share), portfolio performance data (occupancy, ABR, lease terms), acquisition and disposition activity, capital markets activity, balance sheet metrics, dividend information, and updated 2026 guidance. This is a standard quarterly earnings release disclosing results of operations and financial condition under Item 2.02.

View raw filing on EDGAR →

Athene Holding Ltd. (ATH-PE)

8-K Earnings release confidence 94% filed 2026-08-05 Item 2.02

Athene Holding Ltd. disclosed preliminary financial results for Q2 2026 (three and six months ended June 30, 2026), including condensed consolidated balance sheet, statement of income, invested assets flows, and spread-related earnings metrics. The disclosure presents comprehensive financial results and operational metrics that materially affect investor assessment of the registrant's financial performance and condition.

View raw filing on EDGAR →

MADISON GAS & ELECTRIC CO

8-K Earnings release confidence 97% filed 2026-08-05 Item 2.02

MGE Energy issued a press release on August 5, 2026 announcing second quarter 2026 earnings of $33.4 million ($0.89 per share) versus $26.5 million ($0.72 per share) in Q2 2025, along with six-month results and detailed financial tables for both periods.

View raw filing on EDGAR →

Velocity Financial, Inc. (VEL)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a clear earnings release disclosing Velocity Financial's second quarter 2026 financial results. The Item 2.02 disclosure explicitly states "On August 5, 2026 we issued a press release announcing financial results for the quarter ended June 30, 2026," with the press release attached as Exhibit 99.1. The exhibit contains comprehensive quarterly financial statements, including net income of $25.2 million, diluted EPS of $0.64, and detailed operating metrics—all hallmarks of a standard quarterly earnings announcement.

View raw filing on EDGAR →

Velocity Financial, Inc. (VEL)

8-K Earnings release confidence 95% filed 2026-08-05 Item 7.01

The filing discloses Velocity Financial's second quarter 2026 earnings presentation, including net income of $25.2 million, diluted EPS of $0.64, core net income of $27.9 million, and core diluted EPS of $0.71, along with comprehensive financial metrics and portfolio performance data. This is a standard quarterly earnings disclosure furnished via Item 7.01 (Regulation FD Disclosure) with the presentation attached as Exhibit 99.

View raw filing on EDGAR →

BIODESIX INC (BDSX)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a straightforward earnings release for Q2 2026 ended June 30, 2026, filed on August 5, 2026. The press release (Exhibit 99.1) announces financial and operating results including revenue of $26.9 million (34% growth), gross margin of 82%, and net loss of $7.3 million, along with full-year 2026 guidance. The Item 2.02 disclosure explicitly states the company "issued a press release announcing the financial and operating results" and incorporates the exhibit by reference, which is the standard format for earnings releases on Form 8-K.

View raw filing on EDGAR →

MANNKIND CORP (MNKD)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

MannKind Corporation issued a press release on August 5, 2026 disclosing Q2 2026 financial results, including total revenues of $109.4M (+43% vs. Q2 2025), along with consolidated statements of operations and balance sheets. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes detailed revenue breakdowns, operating expenses, and net loss of $19.0M for Q2 2026.

View raw filing on EDGAR →

WARRIOR MET COAL, INC. (HCC)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a clear earnings release for Q2 2026 results. The Item 2.02 disclosure states "Warrior Met Coal, Inc. (the 'Company') issued a press release announcing the Company's second quarter 2026 results," with the press release attached as Exhibit 99.1. The exhibit contains detailed financial results including net income of $87.4 million ($1.65 per diluted share), adjusted EBITDA of $156.9 million, revenues of $509.7 million, and operational metrics. This is material to investors as it reports significant earnings growth and operational improvements driven by Blue Creek mine ramp-up.

View raw filing on EDGAR →

Onterris, Inc. (ONT)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Onterris disclosed Q2 2026 financial results (revenue $186.7 million, net income $1.4 million/$0.04 EPS, Adjusted EBITDA $31.9 million) and significantly reduced full-year 2026 guidance due to historically low environmental emergency response revenues, lowering Consolidated Adjusted EBITDA guidance from $125.0–$130.0 million to $117.0–$120.0 million and revenue guidance from $840.0–$900.0 million to $740.0–$790.0 million.

View raw filing on EDGAR →

CoreCivic, Inc. (CXW)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

CoreCivic issued a press release on August 5, 2026 announcing Q2 2026 financial results, including total revenue of $684.9 million (27.3% increase), net income of $37.1 million, diluted EPS of $0.37, and updated full-year 2026 guidance.

View raw filing on EDGAR →

Revolution Medicines, Inc. (RVMDW)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

This is a quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) filed under Item 2.02 (Results of Operations and Financial Condition). The press release discloses financial results including R&D expenses of $394.9M, G&A expenses of $110.2M, and net loss of $644.4M for the quarter, along with cash position of $3.9B and updated full-year 2026 operating expense guidance of $2.1–$2.2B. The filing includes the full press release as Exhibit 99.1, which is the standard format for earnings disclosures.

View raw filing on EDGAR →

IonQ, Inc. (IONQ-WT)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

IonQ issued a press release on August 5, 2026 announcing Q2 2026 financial results, including record GAAP revenues of $80.1 million (287% YoY growth), net loss of $1.87 billion, and raised full-year 2026 guidance to $280–$290 million. This is a standard quarterly earnings release filed under Item 2.02 and furnished as Exhibit 99.1, meeting the definition of earnings_release.

View raw filing on EDGAR →

Red Violet, Inc. (RDVT)

8-K Earnings release confidence 92% filed 2026-08-05 Item 2.02

Red Violet disclosed preliminary financial results for Q2 2026 (three months ended June 30, 2026), including revenue of $26.7 million, net income of $4.96 million, and adjusted EBITDA of $11.22 million. The disclosure includes key operating metrics and a GAAP-to-non-GAAP reconciliation.

View raw filing on EDGAR →

WW INTERNATIONAL, INC. (WW)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

WW International issued a press release and Shareholder Letter on August 5, 2026 announcing financial results for its fiscal quarter ended June 30, 2026. The disclosure includes Q2 2026 revenue of $162.3 million, subscriber metrics, gross margin of 70.3%, net income of $14.1 million, and reaffirmed full-year 2026 guidance. This is a standard quarterly earnings release filed under Item 2.02 with exhibits 99.1 and 99.2 attached.

View raw filing on EDGAR →

Sarepta Therapeutics, Inc. (SRPT)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Sarepta issued a press release on August 5, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 net product revenues of $328.7 million, GAAP operating income of $13.3 million, and non-GAAP operating income of $86.5 million. The filing explicitly states this is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes detailed financial metrics, revenue breakdowns, and forward guidance narrowing FY 2026 total net product revenue guidance to $1.2-$1.3 billion.

View raw filing on EDGAR →

Alpha Teknova, Inc. (TKNO)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Alpha Teknova issued a press release on August 5, 2026 announcing Q2 2026 financial results, including revenue of $12.2 million (up 18% YoY), gross profit, operating expenses, net loss, and cash flow metrics. The company also raised its 2026 revenue guidance to $45-47 million and improved Free Cash Outflow expectations. This is a standard quarterly earnings disclosure furnished under Item 2.02, with detailed financial statements and forward-looking guidance that would materially affect investor assessment of the company's financial performance and trajectory.

View raw filing on EDGAR →

Great Elm Capital Corp. (GECCO)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Great Elm Capital Corp. issued a press release on August 5, 2026, disclosing its second quarter 2026 financial results, including net investment income of $0.32 per share, NAV of $7.95 per share, and net realized and unrealized gains of $1.9 million. The filing includes complete financial statements (balance sheet and income statement) and management commentary on quarterly performance, which are hallmarks of a quarterly earnings release under Item 2.02.

View raw filing on EDGAR →

AIRGAIN INC (AIRG)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Item 2.02 discloses Airgain's financial results for Q2 2026 (quarter ended June 30, 2026) via press release dated August 5, 2026. The filing reports quarterly revenue of $13.7 million, GAAP net loss of $1.7 million, and adjusted EBITDA of $0.4 million, along with Q3 2026 financial guidance. This is a standard quarterly earnings release materially affecting investor assessment of the company's financial performance and outlook.

View raw filing on EDGAR →

Biomea Fusion, Inc. (BMEA)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Biomea Fusion issued a press release on August 5, 2026 announcing its financial results for the quarter ended June 30, 2026, including condensed statements of operations and balance sheet data. The disclosure includes net loss of $8.3 million for Q2 2026, R&D and G&A expense details, cash position of $35.2 million, and cash runway projections into Q2 2027. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, material to investors assessing the company's financial condition and burn rate.

View raw filing on EDGAR →

U-Haul Holding Co /NV/ (UHAL-B)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

U-Haul issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing net earnings of $122.9 million (down from $142.3 million in the prior year), earnings per share of $0.63 (down from $0.73), and detailed segment performance metrics. This is a standard quarterly earnings release furnished under Item 2.02, with the full press release attached as Exhibit 99.1.

View raw filing on EDGAR →

BARRETT BUSINESS SERVICES INC (BBSI)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

BBSI reported Q2 2026 financial results with revenues of $319.3 million (up 4%), gross billings of $2.29 billion (up 3%), and net income of $12.9 million or $0.52 per diluted share, along with forward-looking guidance for 2026 gross billings and WSE growth.

View raw filing on EDGAR →

Sight Sciences, Inc. (SGHT)

8-K Earnings release confidence 97% filed 2026-08-05 Item 2.02

Sight Sciences issued a press release on August 5, 2026 announcing Q2 2026 financial results with revenue of $23.4 million (20% YoY growth) and raised full-year 2026 revenue guidance to $88–$92 million while reducing adjusted operating expense guidance to $92–$94 million.

View raw filing on EDGAR →

Tenaya Therapeutics, Inc. (TNYA)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Tenaya Therapeutics issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, including condensed statements of operations and balance sheet data. The filing discloses Q2 2026 net loss of $43.4 million (versus $23.3 million in Q2 2025), R&D and G&A expenses, and cash position of $78.1 million. This is a standard quarterly earnings release with financial statements and operational updates, fitting the earnings_release category under Item 2.02.

View raw filing on EDGAR →

Enliven Therapeutics, Inc. (ELVN)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

This is a clear earnings release disclosing Enliven's Q2 2026 financial results, including R&D expenses ($29.0M), G&A expenses ($8.2M), net loss ($32.5M), and cash position ($895.2M). The press release is attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings announcements. The disclosure includes both financial statements and operational highlights regarding the ELVN-001 clinical program.

View raw filing on EDGAR →

Aeva Technologies, Inc. (AEVA)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Aeva Technologies disclosed Q2 2026 quarterly financial results, reporting revenue of $6.1 million, GAAP operating loss of $34.6 million, and GAAP net loss per share of $1.23, along with balance sheet and cash flow data.

View raw filing on EDGAR →

Paycom Software, Inc. (PAYC)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Paycom issued a press release on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 total revenues of $531.2 million (up 9.8% YoY), GAAP net income of $107.4 million ($2.34 per diluted share), and raising full-year 2026 guidance. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings releases.

View raw filing on EDGAR →

STANDARD BIOTOOLS INC. (LAB)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Standard BioTools issued a press release on August 5, 2026 disclosing financial results for the three and six months ended June 30, 2026, including revenue of $20.1 million for Q2 2026, gross margins of 52.4%, operating loss of $25.4 million, and adjusted EBITDA loss of $2.5 million.

View raw filing on EDGAR →

MYOMO, INC. (MYO)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure announces financial results including revenue of $11.7 million (up 21% YoY), gross margin expansion to 72.1%, and improved operating losses. The company also raised full-year revenue guidance to $45-47 million. The press release is furnished as Exhibit 99.1 and includes detailed financial statements and forward-looking guidance, which are hallmarks of a material earnings announcement.

View raw filing on EDGAR →

VERRA MOBILITY Corp (VRRM)

8-K Earnings release confidence 94% filed 2026-08-05 Item 2.02

Verra Mobility disclosed Q2 2026 financial results on August 5, 2026, reporting total revenue of $263.6 million and a net loss of $(48.2) million, along with revised full-year 2026 guidance and a conference call announcement. The earnings release, furnished as Exhibit 99.1, includes comprehensive segment performance and material business developments.

View raw filing on EDGAR →

Block, Inc. (BSQKZ)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Block, Inc. issued a Shareholder Letter on August 5, 2026 announcing financial results for Q2 2026 ended June 30, 2026. The letter discloses key financial metrics including gross profit of $3.17B (+25% YoY), operating income of $447M, and diluted EPS of $0.15, along with a raised full-year guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is material to investors assessing the company's financial performance and outlook.

View raw filing on EDGAR →

Dave Inc./DE (DAVEW)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Dave Inc. issued a press release on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026 (Q2 2026). The disclosure includes quarterly revenue of $170.8 million (30% Y/Y growth), net income of $6.7 million, adjusted EBITDA of $75.5 million (48% Y/Y growth), and updated full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted diluted EPS. This is a standard quarterly earnings release with detailed financial statements and operating metrics, filed under Item 2.02 as required for earnings disclosures.

View raw filing on EDGAR →

Pursuit Attractions & Hospitality, Inc. (PRSU)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

The filing discloses Pursuit's financial results for the second quarter ended June 30, 2026, including record revenue of $133.5 million (14.3% YoY growth), net income of $15.2 million, and Adjusted EBITDA of $32.7 million. The company also updated full-year 2026 guidance upward by $5 million in Adjusted EBITDA to $128–$138 million. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.

View raw filing on EDGAR →

SAIA INC (SAIA)

8-K Earnings release confidence 95% filed 2026-08-05 Item 7.01

The Item 7.01 disclosure furnishes a conference call transcript discussing Saia's second quarter 2026 earnings results. The filing explicitly states it is "the transcript of the conference call to discuss the second quarter earnings of Saia, Inc." The transcript contains detailed financial results including record revenue of $956.5 million (17.1% YoY increase), operating income of $125 million (26% YoY increase), operating ratio of 86.9%, and diluted EPS of $3.51 (31.5% YoY increase). This is a material earnings disclosure that would affect a reasonable investor's assessment of the company's financial performance.

View raw filing on EDGAR →

Apple Hospitality REIT, Inc. (APLE)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Apple Hospitality REIT announced its financial results for the three and six months ended June 30, 2026, via press release furnished as Exhibit 99.1. The disclosure includes comprehensive quarterly and year-to-date financial metrics (net income, operating income, EBITDA, MFFO, RevPAR, occupancy, ADR) and management commentary on operational performance, refinancing activities, and capital allocation. This is a standard earnings release disclosure under Item 2.02.

View raw filing on EDGAR →